Preclinical evaluation of a GFRA1 targeted antibody-drug conjugate in breast cancer-Reference-Cited by-同舟云学术

Preclinical evaluation of a GFRA1 targeted antibody-drug conjugate in breast cancer

Published:2018-05-01 Issue:33 Volume:9 Page:22960-22975
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Bosco Emily E.¹,Christie R. James²,Carrasco Rosa¹,Sabol Darrin¹,Zha Jiping³⁴,DaCosta Karma³,Brown Lee⁵,Kennedy Maureen¹,Meekin John¹,Phipps Sandrina²,Ayriss Joanne²⁶,Du Qun²,Bezabeh Binyam²⁷,Chowdhury Partha²⁸,Breen Shannon¹,Chen Cui¹,Reed Molly⁹,Hinrichs MaryJane⁹,Zhong Haihong¹,Xiao Zhan¹,Dixit Rakesh⁹,Herbst Ronald¹,Tice David A.¹

Affiliation:

1. Oncology Research, MedImmune, LLC, Gaithersburg, Maryland, United States of America

2. Antibody Discovery and Protein Engineering, MedImmune, LLC, Gaithersburg, Maryland, United States of America

3. Pathology, MedImmune, LLC, Gaithersburg, Maryland, United States of America

4. Translational Sciences, NGM Biopharmaceuticals, South San Francisco, California, United States of America

5. Pathology, MedImmune, Ltd, Cambridge, United Kingdom

6. Department of Global Biotherapeutics, Pfizer, Cambridge, Massachusetts, United States of America

7. Research, Salubris Biotherapeutics, Gaithersburg, Maryland, United States of America

8. Biologics Discovery, Sanofi Genzyme, Cambridge, MA, United States of America

9. Biologics Safety Assessment, MedImmune, LLC, Gaithersburg, Maryland, United States of America

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. WTAP‐mediated m6A modification of circ_0032463 promotes osteosarcoma progression by sponging miR‐145‐5p and regulating GFRA1 expression;Journal of Biochemical and Molecular Toxicology;2024-09

2. REThinking the role of the RET oncogene in breast cancer;Frontiers in Oncology;2024-08-01

3. A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression;Clinical Cancer Research;2023-11-15

4. Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer;Cancer Research;2023-04-18

5. A Bayesian multivariate mixture model for high throughput spatial transcriptomics;Biometrics;2022-08-10